If approved, the pill is expected to be far easier to administer than current injectables—and far easier to manufacture
UnitedHealth stock to cut 715 points off the Dow’s price after earnings debacle
The stock is set to suffer its worst day since 1998 after the first quarterly earnings miss in years and the full-year outlook was slashed.
